Current and interested shareholders can register for the webcast here: Bell Potter | Healthcare 2025 (EXT) ...
The notice was received by the China National Intellectual Property AdministrationVancouver, Canada, Nov. 12, 2025 (GLOBE NEWSWIRE) -- ...
Psyence BioMed (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived ...
Secures royalty economic interests in two early stage partnered assets through XOMA Royalty's announced expected acquisition of LAVA Therapeutics. Company acquisitions: •Completed ...
Researchers at the University of Southampton have developed an artificial intelligence (AI) tool that can spot hard-to-see ...